Head & Neck Cancer Drugs Market to Reach $2.28 Bn by 2025 at 7.3% CAGR Globally, Says Allied Market Research Portland, OR, March 04, 2019 (GLOBE NEWSWIRE) -- Allied Market Research recently published a report, titled, “Head & Neck Cancer Drugs Market by Drug Class (Chemotherapy, Immunotherapy, and...